Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematological Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01816022
What this trial is testing

Myeloproliferative Neoplasms and Bone Structure

Who this might be right for
Polycythemia VeraThrombocythemia, EssentialPrimary Myelofibrosis
University of Southern Denmark 125
Testing effectiveness (Phase 2)Active Not RecruitingNCT01628029
What this trial is testing

Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmSleep Disorder
M.D. Anderson Cancer Center 68
Not applicableNot Yet RecruitingNCT07734272
What this trial is testing

Standardized Documentation and Assessments for Polycythemia Vera: A Quality Improvement Initiative

Who this might be right for
Polycythemia Vera
Massachusetts General Hospital 32
Very early researchWithdrawnNCT05015972
What this trial is testing

UCAR-T for CD19+ Refractory/Relapsed B Hematologic Malignancies

Who this might be right for
B-cell Lymphoma
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Testing effectiveness (Phase 2)Ended earlyNCT02712905
What this trial is testing

An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies

Who this might be right for
Solid Tumors and Hematologic Malignancy
Incyte Corporation 116
Testing effectiveness (Phase 2)Looking for participantsNCT05092451
What this trial is testing

Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances

Who this might be right for
B-Cell LymphomaMyelodysplastic Syndromes (MDS)Acute Myeloid Leukemia (AML)+7 more
M.D. Anderson Cancer Center 80
Not applicableStudy completedNCT01021683
What this trial is testing

The Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised Participants

Who this might be right for
Hematologic NeoplasmsNeutropeniaFever
Janssen Korea, Ltd., Korea 203
Not applicableStudy completedNCT07069153
What this trial is testing

Laser vs Ozone Therapy for Oral Mucositis in Cancer Patients

Who this might be right for
Oral MucositisHead and Neck NeoplasmsHematologic Neoplasms
University of Pavia 40
Testing effectiveness (Phase 2)Study completedNCT00241241
What this trial is testing

Efficacy and Safety of Pegylated Interferon Alfa in Polycythemia Vera

Who this might be right for
Polycythemia Vera
PV-Nord 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439344
What this trial is testing

Testing Binimetinib as a Potential Targeted Treatment in Cancers With NRAS Genetic Changes (MATCH-Subprotocol Z1A)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 53
Early research (Phase 1)Study completedNCT00476177
What this trial is testing

Donor Dendritic Cells And Donor Lymphocytes in Patients With Relapsed Hematologic Malignancies After Allogeneic Transplant

Who this might be right for
Hematologic Malignancy
Dana-Farber Cancer Institute 25
Not applicableLooking for participantsNCT06469307
What this trial is testing

Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)

Who this might be right for
Blood CancerLeukemia
Dana-Farber Cancer Institute 40
Not applicableEnded earlyNCT01685411
What this trial is testing

Busulfan and Cyclophosphamide Followed By ALLO BMT

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome
Masonic Cancer Center, University of Minnesota 5
Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Early research (Phase 1)Study completedNCT00357305
What this trial is testing

Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic Leukemia+31 more
National Cancer Institute (NCI) 25
Not applicableActive Not RecruitingNCT04142372
What this trial is testing

Tissue Microarray of Hematological Malignancies

Who this might be right for
Hematological Malignancies
Tampere University Hospital 5,000
Testing effectiveness (Phase 2)Study completedNCT00002792
What this trial is testing

Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic/Myeloproliferative Diseases
Fred Hutchinson Cancer Center 20
Early research (Phase 1)Looking for participantsNCT06732492
What this trial is testing

RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell Malignancies

Who this might be right for
NK T-Cell LymphomaCART TherapyCD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 10
Very early researchLooking for participantsNCT06636175
What this trial is testing

64Cu-LLP2A for Imaging Hematologic Malignancies

Who this might be right for
Multiple MyelomaLow-Grade LymphomaFollicular Lymphoma+4 more
Washington University School of Medicine 42
Not applicableLooking for participantsNCT05475600
What this trial is testing

APA and Relaxation by Biofeedback in Patients With Haematological Malignancy Admitted in ICU

Who this might be right for
Adapted Physical ActivityHematological MalignanciesAnxiety+1 more
Centre Hospitalier Régional Metz-Thionville 90
Next Page